Impact of a pharmacist-led asthma and COPD respiratory clinic in general practice – The Pharmaceutical Journal

Impact of a pharmacist-led asthma and COPD respiratory clinic in general practice
The Pharmaceutical Journal
Asthma and chronic obstructive pulmonary disease (COPD) continue to account for a large burden of disease in the UK. Despite comprehensive guidelines, more than 1,000 people die from asthma each year and COPD accounts for a leading cause of …

View full post on asthma – Google News

[Prevalence of asthma consultations in general practice].

[Prevalence of asthma consultations in general practice].

Rev Mal Respir. 2016 Mar 9;

Authors: Schuers M, Chopinaud PA, Guihard H, Mercier A

Abstract
INTRODUCTION: Few data from primary care settings are available about asthma prevalence. The aim of this study was to evaluate the prevalence of asthma consultations in general practice, and to describe their characteristics.
METHODS: This was a multicenter, cross-sectional national study, conducted in general practice. Investigators were 54 interns from 27 medical schools. Between December 2011 and April 2012, they collected and entered variables specific to each consultation over a period of 20 days from a structured electronic health record using the International classification of primary care (ICPC-2) together with data about their trainer(s).
RESULTS: Data were recorded for 20,613 consultations with 45,582 consultation outcomes described. Asthma represented 348 (1.69%) of consultations. The presence of an asthma code was associated with fewer reasons for the consultation, but with more processes of care. Forty-two percent of other consultation results associated with asthma in the same consultation concerned chronic diseases.
CONCLUSION: Our findings suggest that asthma remains underdiagnosed in general practice in France. In order to address this problem, the development of validated diagnostic tools that can be used in general practice settings, and a better access to spirometry, may be directions to explore in future research.

PMID: 26971076 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Asthma, Heart Disease, Cancer and General Illness Found in Kentucky … – PR Newswire (press release)

Asthma, Heart Disease, Cancer and General Illness Found in Kentucky
PR Newswire (press release)
BEREA, Ky., March 18, 2013 /PRNewswire-USNewswire/ — A study published in the Journal of Rural Health reveals that people living in communities where mountaintop removal (MTR) mining occurs experience higher levels of illness compared to

and more »

View full post on asthma – Google News

Asthma, Heart Disease, Cancer and General Illness Found in Kentucky … – Sacramento Bee

Asthma, Heart Disease, Cancer and General Illness Found in Kentucky
Sacramento Bee
Data shows higher reported incidences of asthma; chronic obstructive pulmonary disease; illnesses involving multiple organs; and general illness. MTR community residents also reported more serious illness and cancer deaths in family members, than

and more »

View full post on asthma – Google News

Attorney General urging new standards on pollutants that contribute to asthma – Connectcut Plus

Attorney General urging new standards on pollutants that contribute to asthma
Connectcut Plus
HARTFORD, CT – Attorney General George Jepsen has joined with the Attorneys General of eight other states in urging federal regulators to adopt new standards for fine particulate matter, a type of air pollutant that contributes to respiratory symptoms

and more »

View full post on asthma – Google News

Nocturnal gastroesophageal reflux, asthma and symptoms of obstructive sleep apnoea: a longitudinal, general population study.

Related Articles

Nocturnal gastroesophageal reflux, asthma and symptoms of obstructive sleep apnoea: a longitudinal, general population study.

Eur Respir J. 2012 Sep 27;

Authors: Emilsson OI, Bengtsson A, Franklin KA, Torén K, Benediktsdóttir B, Farkhooy A, Weyler J, Dom S, Backer WD, Gislason T, Janson C

Abstract
Nocturnal gastroesophageal reflux (nGER) is associated with asthma and obstructive sleep apnoea (OSA). Our aim was to investigate whether nGER is a risk factor for onset of asthma and onset of respiratory and OSA symptoms in a prospective population based study.We invited 2640 subjects from Iceland, Sweden and Belgium for two evaluations over a nine years interval. They participated in structured interviews, answered questionnaires, underwent spirometries and methacholine challenge testing. nGER was defined by reported symptoms.Subjects with persistent nGER (n=123) had an independent increased risk of new asthma at follow-up [OR (95% CI): 2.3 (1.1-4.9)]. Persistent nGER was independently related to onset of respiratory symptoms [OR (95% CI): 3.0 (1.6-5.6)]. The risk of developing symptoms of OSA was increased in subjects with new and persistent nGER [OR (95% CI): 2.2 (1.3-1.6) and 2.0 (1.0-3.7), respectively]. No significant association was found between nGER and lung function or bronchial responsiveness.Persistent symptoms of nocturnal gastroesophageal reflux contributes to the development of asthma and respiratory symptoms. New onset of OSA symptoms is higher among subjects with symptoms of nGER. These findings support that nGER may play a role in the genesis of respiratory symptoms and diseases.

PMID: 23018910 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Allegheny General Hospital and the Breathe Project Present “The Air We Breathe … – MarketWatch (press release)

Allegheny General Hospital and the Breathe Project Present "The Air We Breathe
MarketWatch (press release)
Local and national asthma experts will convene in Pittsburgh May 16 in recognition of World Asthma Month for "The Air We Breathe: A Regional Summit on Asthma and the Environment," a day-long event designed to raise awareness about the growing incidence

and more »

View full post on asthma – Google News